Drug interactions between Fasigyn and fluconazole
Interactions between your drugs
A total of 191 drugs (853 brand and generic names) are known to interact with Fasigyn.
- Fasigyn is in the drug class amebicides.
- Fasigyn is used to treat the following conditions:
- Fluconazole is a member of the drug class azole antifungals.
- Fluconazole is used to treat the following conditions:
- Bone Marrow Transplantation
- Candida Urinary Tract Infection
- Chronic Mucocutaneous Candidiasis
- Coccidioidomycosis, Meningitis
- Cryptococcal Meningitis, Immunocompetent Host
- Cryptococcal Meningitis, Immunosuppressed Host
- Esophageal Candidiasis
- Fungal Infection Prophylaxis
- Fungal Infection, Internal and Disseminated
- Fungal Peritonitis
- Fungal Pneumonia
- Onychomycosis, Fingernail
- Onychomycosis, Toenail
- Oral Thrush
- Systemic Candidiasis
- Tinea Corporis
- Tinea Cruris
- Tinea Versicolor
- Vaginal Yeast Infection
Drug and food interactions
Applies to: Fasigyn (tinidazole)
Consumer information for this interaction is not currently available.
GENERALLY AVOID: Use of alcohol or products containing alcohol during nitroimidazole therapy may result in a disulfiram-like reaction in some patients. There have been a few case reports involving metronidazole, although data overall are not convincing. The presumed mechanism is inhibition of aldehyde dehydrogenase (ALDH) by metronidazole in a manner similar to disulfiram. Following ingestion of alcohol, inhibition of ALDH results in increased concentrations of acetaldehyde, the accumulation of which can produce an unpleasant physiologic response referred to as the 'disulfiram reaction'. Symptoms include flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, vomiting, sweating, thirst, chest pain, palpitation, dyspnea, hyperventilation, tachycardia, hypotension, syncope, weakness, vertigo, blurred vision, and confusion. Severe reactions may result in respiratory depression, cardiovascular collapse, arrhythmia, myocardial infarction, acute congestive heart failure, unconsciousness, convulsions, and death. However, some investigators have questioned the disulfiram-like properties of metronidazole. One study found neither elevations in blood acetaldehyde nor objective or subjective signs of a disulfiram-like reaction to ethanol in six subjects treated with metronidazole (200 mg three times a day for 5 days) compared to six subjects who received placebo.
MANAGEMENT: Because clear evidence is lacking concerning the safety of ethanol use during nitroimidazole therapy, patients should be apprised of the potential for interaction and instructed to avoid alcoholic beverages and products containing alcohol or propylene glycol while using oral, intravenous, or vaginal preparations of a nitroimidazole. Alcoholic beverages should not be consumed for up to 3 days after completion of systemic nitroimidazole therapy.
Therapeutic duplication warnings
No therapeutic duplications were found for your selected drugs.
Drug Interaction Classification
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.